XML 21 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations
6 Months Ended
Dec. 31, 2022
Discontinued Operations:  
Discontinued Operations

7. Discontinued Operations

 

Following the end of the COVID cannabis delivery boom, along with a challenging cannabis retail climate from inflation, the black market, increased marketing expenses, and the cannabis excise tax moving from distribution to retail, the company has decided to reduce investments in retail operations. The company made this decision as we see more promising opportunities to increase shareholder equity by pivoting the business strategy to deploy capital to invest in cannabis real estate, cultivation, and wholesale sectors vs. cannabis retail operations.

 

After discussions with ECGI, Inc. and the management of Nug Avenue, we could not find a path to short term profitability. The company then decided to cease investing in Nug Avenue, which ultimately led to Nug Avenue discontinuing operations.

 

The Company has reclassified its previously issued financial statements to segregate the discontinued operations as of the earliest period reported.

 

Assets and liabilities related to the discontinued operations were as follows:

 

   December 31, 2022   June 30, 2022 
   (Unaudited)   (Audited) 
Assets          
Current assets:          
Other current assets   70,723    70,723 
Total current assets   70,723    70,723 
Noncurrent assets:          
Property, plant and equipment, net   4,715    16,492 
Intangible asset, net   2,256    3,222 
Total noncurrent assets   6,971    19,714 
Total assets   77,692    90,436 
           
Liabilities and Stockholders’ Deficiency          
Current liabilities:          
Accounts payable and accrued liabilities   675,319    675,012 
Loan payable - Related Parties, Current   1,657,444    1,633,097 
Total liabilities   2,332,763    2,308,109 
           
Stockholders’ equity (deficiency):          
Additional paid-in capital   869,045    869,045 
Accumulated deficit   (3,174,122)   (3,136,725)
Total stockholders’ equity (deficiency)   (2,305,077)   (2,267,680)
Non-Controlling Interest   50,007    50,007 
Total stockholders’ equity (deficiency)   (2,255,070)   (2,217,673)
Total liabilities and stockholders’ equity (deficiency)   77,692    90,436 

 

   December 31, 2022   December 31, 2021   December 31, 2022   December 31, 2021 
   For the three Months Ended   For the six Months Ended 
   December 31, 2022   December 31, 2021   December 31, 2022   December 31, 2021 
Revenues, net   -    697,010    -    1,427,248 
Cost of goods sold   -    -    -    - 
Gross profit   -    697,010    -    1,427,248 
                     
Selling, general and administrative expenses   9,955    346,765    11,918    641,247 
Advertising and promotion expense   -    541,173    -    1,054,640 
Marketing and research expense   -    -    -    985 
Professional expense   14,513    106,700    24,513    220,635 
Salaries and wages   -    392,588    -    713,555 
Total operating expenses   24,468    1,387,226    36,431    2,631,062 
                     
Loss from continuing operations   (24,468)   (690,215)   (36,431)   (1,203,815)
                     
Non-operating income (expense):                    
Other (expense) income   -    -    -    (105)
Interest expense   -    (135)   -    (178)
Amortization of intangible assets   (483)   (483)   (967)   (967)
Total nonoperating expenses   (483)   (618)   (967)   (1,249)
                     
Loss before income taxes   (24,951)   (690,833)   (37,397)   (1,205,064)
Income tax expense   -    -    -    - 
Net loss from operations   (24,951)   (690,833)   (37,397)   (1,205,064)